Limited Project Grant Recipients | Dates | Title | Investigator | Institution | Amount | 1/1/90-2/14/91 | Effect of Somatostatin Analog on ColonCancer in Mice | Martin A. Luchtefeld, MD | FergusonClinic | $4,637 | 2/1/90-1/31/91 | Detection of Familial Adenomatous Polyposis by DNA Analysis | Philip Paul, Ph.D | ClevelandClinic | $11,992 | 3/1/90-6/1/91 | Anorectal Motility & the Rectal Motor Complex | Bruce A. Orkin, MD | George Washington Univ. | $19,893 | 7/1/90-6/30/93 | Transformed Skeletal Muscle Neo-Sphincter | David A. Rothenberger, MD | Inst Applied & Basic Research | $65,110 | 1/15/91-11/15/92 | Selenium, Iron & Folate in ColonCancer & Adenomas | Richard L. Nelson, MD | U of IL Hosp-U of IL | $11,705 | 1/1/92-12/31/92 | The Voluntary Inhibition Action: A Putataive Reflex | David H. Levien, MD | New York Medical College | $16,882 | 1/1/92-9/30/94 | Prognostic Value of Nuclear Shape in Colorectal Carcinoma | Philip H. Gordon, MD | Jewish Gen Hospital | $22,457 | 3/1/92-2/28/93 | Mutated P53 & the Prognosis of Colorectal Cancer | S. David Nathanson, MD | Henry Ford Hosp | $19,615 | 1/1/-12/31/94 | Histochemical Analysis of Striated Anal Sphincters | James M. Church, MD | ClevelandClinic | $4,560 | 8/1/92-7/31/93 | Blood Flow in ColonAnastomatic Stricture Formation | Charles P. Orsay, MD | Research | $20,614 | 1/1/93-12/31/93 | Prevalence of Fecal Incontinence in Wisconsin | Nancy Norton, B.S. | Intl Fndn for Bowel Dsyfunction | $5,300 | 9/1/93-8/31/94 | Manipulation of Liver Tumor Blood Flow Using ATP-MgCL2 | Jeffrey W. Milsom, MD | ClevelandClinic | $29,907 | 1/1/-12/31/94 | Optimization of Bifunctional Antibody Therapy | Heidi Nelson, MD | Mayo Clinic & Foundation | $33,596 | 4/15/96-4/15/97 | hMSH2 and hMLH1 Mutations in Hereditary Colon Cancer | Thomas K. Weber, MD | Roswell Park Cancer Institute | $16,650 | 4/15/96-4/15/97 | Protein Kinase C Isoforms and ColonCancer Prognosis | Jose G. Guillem, MD | Sloan Kettering Inst. Cancer Rsch. | $26,094 | 9/1/96-9/1/97 | A Randomized Controlled Clinical Trial Comparing Topical Nitroglycerin to Sphincterotomy in the Treatment of Chronic Anal Fissures | Robin S. McLeod, MD | Mount Sinai Hospital | $17,000 | 11/1/97-10/31/98 | Bowel Permeability in Patients with Crohn's Disease | Walter A. Koltun, MD | Milton S. Hershey Med Ctr | $23,068 | 11/1/97-10/31/98 | Chemoprevention in a Murine Model of Familial Adenamatous Polyposis | Najjia N. Mahmoud, MD | Cornell University Med Ctr | $20,013 | 12/15/97-12/14/98 | Repair of Fistulae in ano using Autologous Fibrin Tissue Adhesive | Jose R. Cintron, MD | University of Illinois | $15,024 | 8/1/98 - 7/31/99 | Development of an Optimal Immunosuppression Protocol in a Preclinical Model of Small Bowel Transportation | Peter Metrakos, MD | Royal Victoria Hospital | $20,000 | 8/1/98 - 7/31/99 | 12-Lipoxygenase Regulated Growth and Apoptisis in ColonCancer | Charles A. Ternent, MD | Creighton University | $13,352 | 5/1/00 - 4/30/01 | RAGE and Murine Colitis | Emina H. Huang, MD | Columbia University | $25,000 | 1/15/01 - 1/14/02 | The Effect of a Growth Factor on Inflammatory Bowel Disease | Marshall Schwartz, MD | A.I. duPont Hospital | $21,831 | 12/3/01 - 11/30/02 | Predicting Outcomes in Colonand Rectal Cancer Using Population-Based Databases | Clifford Ko, MD | Univ. of California , L A | $21,050 | 12/3/01 - 11/30/02 | Characterization of IL4R-Stat6 Signaling Pathway in IBD | Walter Koltun, MD | Pennsylvania State Univ | $20,062 | 12/3/01 - 11/30/02 | Development of a Validated Measure to Assess Bowel Function after Rectal Cancer Therapy | Larissa Temple , MD | Memorial Sloan Kettering | $19,100 | 12/3/01 - 11/30/02 | Effect of Sulindac on Gene Expression in Rectal Mucosa | Harvey G. Moore, MD | Sloan Kettering Inst. Cancer Rsch. | $24,500 | 12/2/02 - 12/1/03 | The Doctor-Patient Relationship and Colorectal Cancer Screening in Average Risk Individuals | Tracey K. Asano, MD | Mount Sinai Hosp, Toronto | $31,805 | 12/16/02 - 12/15/03 | Determinants of Quality of Life in Rectal Cancer | Stephen Ristvedt, PhD | Washington University, St. Louis | $33,187 | 9/03 - 9/04 | NECRS Quality Project | Neil Hyman, MD | University of Vermont | $45,000 | 11/3/03-11/2/04 | Correlation of NOD2 Gene Variants with Disease Status in | Eva Galka, MD | Pennsylvania State Univ | $41,103 | | Patients with Crohn's Disease | | | | 11/3/03-11/2/04 | Characterization of IL4R-Stat6 Signaling Pathway in IBD | Walter Koltun, MD | Pennsylvania State Univ | $16,808 | 3/01/04-2/28/05 | Hypoxia & Rectal Cancer Response to Chemoradiation | Jose Guillem, MD | Sloan Kettering Inst. | $26,895 | 7/1/05-6/30/06 | Molecular Alterations in Anal Melanoma & Development of Novel Cell Lines | Martin Weiser, MD | Sloan-Kettering Inst. | $40,372 | 7/17/06 - 7/13/07 | Identifying Factors that Influence Ulcerative colitis and Post-Colectomy Utility | Arden Morris, MD | Univ. of Michigan | $40,000 | 9/15/06 - 9/15/07 | Prediction of Lymph Node Involvement in Rectal Cancer | Tobias Leibold, MD | Sloan Kettering Institute for Cancer Research | $27,415 | 7/1/07-6/30/08 | Understanding the Role of the MET Oncogene in Colorectal Cancer Metastasis | Martin Weiser, MD | Sloan Kettering Institute for Cancer Research | $40,562 | | | | Total | $449,690 | Career Development Award Recipients | Dates | Title | Investigator | Institution | Amount | 12/31/01 - 12/31/03 | Tight Junction Structure and Function in Intestinal Inflammation | Lisa S. Poritz, MD | Pennsylvania State Univ Hershey, PA | $80,000 | 12/16/02 - 12/15/04 | The Role of Hyaluronan Biosynthesis in ColonCancer | Kelli M. Bullard, MD | Univ. of Minnesota Minneapolis, MN | $80,000 | 12/16/02 - 12/15/04
<!--[if !supportLineBreakNewLine]-->
<!--[endif]--> | Development of Novel Transrectal Ultrasound Technology | Alan J. Herline, MD | Vanderbilt University Nashville, TN | $80,000 | 3/15/04 - 3/14/06 | Role of VR-1 in Induced & Genetically Engineered Animal Models of Colitis | Christopher Mantyh, MD | Duke Univ. Med. Ctr. | $80,000 | 7/1/05 - 6/30/07 | Salmonella Mediated Interleukin-10 Delivery for the Treatment of IBD | Charles P. Heise, MD | Univ. of Wisconsin Madison | $80,000 | 7/1/05-6/30/07 | Effect of Doxycycline on B-Catenin in APC Mutant Colorectal Tumors | Najjia N. Mahmoud, MD | Hospital of the Univ. of Pennsylvania | $80,000 | 8/15/06 - 8/15/08 | Molecular Signature Predicts
Recurrence of Stage II Colon Cancer | Matthew Mutch, MD | Washington Univ Sch
Med, St. Louis, MO | $80,000 | 7/1/07 - 6/30/09 | Population-Based Analysis of Variability in Sphincter Sparing Surgery | Rocco Ricciardi , MD | Lahey Clinic | $73,167 | 7/1/07 - 6/30/09 | Predictive Genetic Profiling of Early Stage Rectal Cancer | Matthew F. Kalady, MD | ClevelandClinic | $78,625 | | | | Total | $711,792 | International Fellowship Award Recipients | Dates | Title | Investigator | Institution | Amount | 5/1/01 - 4/30/02 | Tumor Growth During Oopen and Laparoscopic Colectomy. The Influence of Acute-Phase Cytokine Response and Acidosis in Angiogenesis. | Miguel Pera, MD | Mayo Clinic, MN | $20,000 | 12/3/01 - 11/30/02 | Tumor Microsatellite Instability, Chemosensitivity and Patient Outcome: A Molecular Reanalysis of Adjuvant 5FU/Leucovorin in ColonCancer | Kouros Moozar , MD | Mt. Sinai Hospital - Toronto | $20,000 | 11/3/03 - 11/2/04 | Measurements of Volatile Thiol Production in Ileal Pouch Contents: Potential Insights into Pathogenesis and Therapy of Pouchitis and Ulcerative Colitis | Hiroki Ohge , MD | University of Minnesota | $20,000 | 3/24/05 - 3/23/06 | Identification of JC Virus in DNA from Colorectal Cancers with Different Types of Genetic Instability | Eui Gon Youk, MD / Julio Garcia-Aguilar, MD | University of California, San Francisco | $20,000 | | | | Total | $80,000 |
|
|
|
|
|
|
|
|
|
